Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any D-2-hydroxyglutaric aciduria in which the cause of the disease is a mutation in the IDH2 gene.
Features include always present findings: D-2-hydroxyglutaric acidemia and D-2-hydroxyglutaric aciduria. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Seizure, Global developmental delay |
Muscles |
IDH2 encodes isocitrate dehydrogenase (NADP(+)) 2 (452 aa). Plays a role in intermediary metabolism and energy production. It may tightly associate or interact with the pyruvate dehydrogenase complex Highest expression in Muscle Skeletal (442.8 TPM) and Heart Left Ventricle (311.5 TPM).
D-2-hydroxyglutaric aciduria 2 is associated with mutations in the IDH2 gene on chromosome 15.
The IDH2 protein participates in SIRT3 deacetylates ACCS2, GLUD, IDH2, SOD2 and NFE2L2-dependent IDH1 gene expression pathways.
IDH2 is classified as a druggable target (Clinically Actionable and Enzyme categories) with score 5.4.
Genetic testing for IDH2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for d-2-hydroxyglutaric aciduria 2.
7 publications have been identified in PubMed for d-2-hydroxyglutaric aciduria 2. Research spans Case Report / Case Series (71%) and Review / Meta-Analysis (29%).
Marcuzzo MB (2026). [PMID: 41831085](https://pubmed.ncbi.nlm.nih.gov/41831085/). *Neurochemical research*. [Review / Meta-Analysis]
Roux J (2025). [PMID: 39839460](https://pubmed.ncbi.nlm.nih.gov/39839460/). *JAAD case reports*. [Case Report / Case Series]
Guo Q (2025). [PMID: 40870031](https://pubmed.ncbi.nlm.nih.gov/40870031/). *Genes*. [Case Report / Case Series]
Tanikawa S (2024). [PMID: 38995357](https://pubmed.ncbi.nlm.nih.gov/38995357/). *Virchows Archiv : an international journal of pathology*. [Case Report / Case Series]
Kühnl T (2024). [PMID: 38668906](https://pubmed.ncbi.nlm.nih.gov/38668906/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:59 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1
Low muscle tone (hypotonia) |
Heart and blood vessels | 1 | Heart muscle disease (cardiomyopathy) |
Garcia I (2024). [PMID: 38919140](https://pubmed.ncbi.nlm.nih.gov/38919140/). *Essays in biochemistry*. [Review / Meta-Analysis]
Gold JI (2024). [PMID: 38736636](https://pubmed.ncbi.nlm.nih.gov/38736636/). *JIMD reports*. [Case Report / Case Series]